Cerebrospinal fluid inflammation during OKT3 therapy.
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002555:Cerebrospinal Fluid / Q000166:cytology; D005260:Female; D006801:Humans; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid* / Q000209:etiology; D008875:Middle Aged
D000911:Antibodies, Monoclonal